US$ 26.84
lixisenatide glp 1 SOLIQUA® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL & 33 mcg/mL A Big Week for GLP-1
Description
Introduction Neuropathic pain is a condition that occurs following a primary lesion or disease impacting the somatosensory nervous system

[DOI] [PubMed] [Google Scholar] 49.Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM

Doctors typically limit use to 12 weeks or less

Iakoubov R, Ahmed A, Lauffer LM, Bazinet RP, Brubaker PL

"There is no way that we can meet those demands with injectable treatments today." This story has been updated with a statement from Novo Nordisk, and new pricing and manufacturing information for orforglipron from Eli Lilly.

This looks like emergency triage
